Edwards Lifesciences Cash Flow from Financial Activities 2010-2025 | EW
Edwards Lifesciences cash flow from financial activities for the twelve months ending March 31, 2025 was $-2.288B, a 107.65% increase year-over-year.
- Edwards Lifesciences annual cash flow from financial activities for 2024 was $-0.983B, a 38.26% increase from 2023.
- Edwards Lifesciences annual cash flow from financial activities for 2023 was $-0.711B, a 55.13% decline from 2022.
- Edwards Lifesciences annual cash flow from financial activities for 2022 was $-1.585B, a 344.71% increase from 2021.